Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Amgen Announces KRAS Safety Update To U.S. Prescribing Information For Vectibix(R) (Panitumumab)
Amgen Inc. (Nasdaq: AMGN) announced the U.S. Food and Drug Administration (FDA) has approved revisions to the U.S. prescribing information for the epidermal growth factor receptor (EGFr) class of antibodies, including Vectibix((R)) (panitumumab). This decision follows the FDA"s December 2008 Oncologics Drugs Advisory Committee (ODAC) meeting where the clinical utility of the KRAS gene as a predictive biomarker in patients with metastatic colorectal cancer (mCRC) treated with anti-EGFr antibody was discussed.

New Fast And Precise Treatment Planning System Among Varian Medical Systems Highlights At American Brachytherapy Society 2009 Meeting
Varian Medical Systems (NYSE: VAR) will be demonstrating its full range of brachytherapy cancer treatment equipment and software at the American Brachytherapy Society meeting in Toronto, Canada, from May 31 to June 2. Varian"s exhibit will include the new BrachyVision™ Acuros™ system, which offers a significantly more accurate* way of calculating the dosimetry of cancer treatments.
News of the day
Pirfenidone May Help Lung Function In IPF Patients According To Large Clinical Trial
A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF.
Health Insurance

Association of American Medical Colleges Praises Nomination Of Francis S. Collins, M.D., Ph.D., To Be New NIH Director

AAMC (Association of American Medical Colleges) President and CEO Darrell G. Kirch, M.D., issued the following statement today on President Obama"s nomination of Francis S. Collins, M.D., Ph.D., to be the new director of the National Institutes of Health (NIH): "The nation"s medical schools and teaching hospitals are very pleased that President Obama"s nominee to be the 16th director of the National Institutes of Health is Dr. Francis Collins. He is an exceptional scientist, administrator, and communicator. Dr. Collins" brilliant leadership of the International Human Genome Sequencing Consortium resulted in the successful completion of the project ahead of schedule and under budget. His skillful direction of this collaborative venture-one of the greatest technical, scientific, and management accomplishments of our lifetime-is just one example of the expertise he will bring to the NIH and its 27 institutes and centers. In addition, Dr. Collins has written eloquently about the potential of medical research to transform how we think about health and health care. America is very fortunate to have a scientist of Dr. Collins" experience, understanding, and vision willing to serve as leader of the world"s foremost biomedical and behavioral research enterprise. The AAMC looks forward to working with Dr. Collins as he leads the NIH forward in this period of tremendous scientific potential and fiscal, administrative, and research challenges." Association of American Medical Colleges


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009